Isoptin Retard (Verapamil Hydrochloride)

Verapamil Hydrochloride blocks L‑type calcium channels in the heart and blood‑vessel walls. By reducing calcium entry into cells, it relaxes vascular smooth muscle, decreases myocardial contractility, slows conduction through the atrioventricular node, and lowers heart rate, which together lower blood pressure and lessen cardiac workload.

The exact dose of Isoptin Retard is determined by the prescribing clinician based on the individual’s medical condition, response to therapy, and other medications. Healthcare professionals adjust the regimen to achieve the desired blood‑pressure or anti‑anginal effect while monitoring safety.

Safety data for verapamil during pregnancy and lactation are limited, and the product is classified as pregnancy category unknown. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using Isoptin Retard.

To place an order, submit an enquiry on the Isoptin Retard product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Isoptin Retard is a non‑dihydropyridine calcium channel blocker, similar to diltiazem, and primarily affects cardiac conduction and contractility. In contrast, dihydropyridine agents such as amlodipine mainly cause peripheral vasodilation with less impact on heart rate. Choice depends on the clinical goal—rate control and anti‑anginal effect versus pure blood‑pressure reduction.

Store Isoptin Retard tablets at ambient temperature, preferably below 25 °C (77 °F). Keep the product in its original container, protect it from moisture and direct sunlight, and ensure the packaging remains tightly closed until use.

Isoptin Retard is taken orally as an extended‑release tablet. The tablet should be swallowed whole with a full glass of water and not crushed, chewed, or split, to maintain the intended release profile and therapeutic effect.

Serious adverse events include marked bradycardia, heart block, severe hypotension, and, rarely, heart failure exacerbation. Patients should seek immediate medical attention if they experience fainting, unusually slow pulse, chest pain, or sudden dizziness, as these may signal life‑threatening complications.

Isoptin Retard is contraindicated in patients with known hypersensitivity to verapamil or any component of the formulation, those with severe sinus‑node dysfunction, second‑ or third‑degree AV block without a pacemaker, and patients in cardiogenic shock or severe hypotension. Clinicians must evaluate each individual’s medical history before prescribing.